| MGLRX | RRGAX | MGLRX / RRGAX | |
| Total Expense Ratio | 0.84 | 1.05 | 80% |
| Annual Report Gross Expense Ratio | 0.85 | 1.43 | 59% |
| Fund Existence | 14 years | 20 years | - |
| Gain YTD | 10.849 | 11.438 | 95% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.19B | 214M | 1,025% |
| Annual Yield % from dividends | 3.04 | 2.57 | 118% |
| Returns for 1 year | 10.54 | 14.05 | 75% |
| Returns for 3 years | 20.37 | 33.64 | 61% |
| Returns for 5 years | -4.79 | 1.20 | -400% |
| Returns for 10 years | 37.79 | 23.60 | 160% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBC | 52.79 | 1.24 | +2.41% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||
| DFNM | 48.35 | 0.02 | +0.04% |
| Dimensional National Municipal Bond ETF | |||
| URNJ | 23.30 | N/A | N/A |
| Sprott Junior Uranium Miners ETF | |||
| MAVF | 136.46 | N/A | N/A |
| MATRIX ADVISORS VALUE ETF | |||
| BOBP | 31.12 | -1.17 | -3.63% |
| Core16 Best Of Breed Premier Index ETF | |||